SCHEMBL3468787

SCHEMBL3468787

C=CCOc1c(CC=C)cccc1OC

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
HPGD P15428 2/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
HSP90AA1 P07900 1/20 0.56
HTT P42858 1/20 0.56
LMNA P02545 2/20 0.54
KDM5A P29375 1/20 0.52
KDM5C P41229 1/20 0.52
POLB P06746 1/20 0.48
BCHE P06276 4/20 0.46
MAPT P10636 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27981723 0.87 ALDH1A1 (0.51) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL19604880 0.87 SMN1; SMN2 (0.58) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL9617754 0.87 ALDH1A1 (0.43) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL3460333 0.86 ALDH1A1 (0.52) KDM4EALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL30681592 0.86 ALDH1A1 (0.52) KDM4EALDH1A1SMN1; SMN2POLBTSHR
SCHEMBL17832018 0.86 SMN1; SMN2 (0.59) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL3461299 0.86 ALDH1A1 (0.57) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL19604879 0.86 LMNA (0.56) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL11602955 0.84 GABRA1 (0.47) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL22215821 0.83 SMN1; SMN2 (0.55) KDM4EALDH1A1SMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 KDM4E 332/4885ALDH1A1 4132/4885SMN1; SMN2 3962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.